key: cord-0767295-bdxj3tt9
authors: Gelaye, Bizu; Foster, Simmie; Bhasin, Manoj; Tawakol, Ahmed; Fricchione, Gregory
title: SARS-CoV-2 Morbidity and Mortality in Racial/Ethnic Minority Populations: A Window into the Stress Related Inflammatory Basis of Health Disparities
date: 2020-10-08
journal: Brain Behav Immun Health
DOI: 10.1016/j.bbih.2020.100158
sha: 39ba5ea37d6f27ff29f3e9fda373e3cbe8e25575
doc_id: 767295
cord_uid: bdxj3tt9

Health disparity related to race/ethnicity has been cited as “the most serious and shameful health care issue of our time”(Peterson et al., 2018). A portion of the now recognized disproportionate impact of the COVID-19 pandemic among Black, Indigenous and People of Color (BIPOC) communities is attributable to social determinants such as socioeconomic status (SES), physical living situation, health care access, and the psychosocial factors associated with socioenvironmental circumstances such as bias, victimization, trauma and toxic stress as well as structural factors that reduce the capacity to practice physical distancing (Agurs-Collins et al., 2019). In this paper, we hypothesize that, prior to the COVID-19 pandemic, disproportionate socio-economic and environmental stressors in the BIPOC population promoted heightened stress-associated neurobiological activity (Stress-NbA). This chronic elevation in Stress-NbA results in down-stream complications of chronic stress including underactivation of anti-viral type I IFN pathway genes. This results in an increase in susceptibility to viral diseases, including coronavirus illnesses. Additionally, Stress-NbA chronically potentiates systemic inflammation (from hematopoietic system activation with myelopoiesis) increasing the prevalence of metabolic syndrome (MetS) and setting the stage for stress-related chronic non-communicable diseases (NCDs). This process was propelled by overactivation of immune cell gene expression in the nuclear factor κ-light-chain-enhancer of activated B cells (NF-kB) activation pathway and underactivation of gene expression in the anti-viral type I interferon (IFN) pathway. The higher prevalence of MetS and NCDs in minority populations turned out to be predictive of the elevated risk they would face in the presence of a highly contagious viral pandemic. The stress-related generation of a chronic non-pathogen associated molecular pattern (non-PAMP) immunoactivation state led to decreased viral immune defense and increased susceptibility to SARS-CoV-2 infection with increased risk of severe illness induced by cytokine storm syndrome (CSS).

Hispanic individuals of low SES report higher levels of stress (Sternthal et al., 2011) . This study also found that members of racial and ethnic minority groups report high rates of exposure to discrimination (Sternthal et al., 2011) . It is known that stress is associated with greater disease vulnerability and this includes infectious communicable diseases (CDs) as well as noncommunicable diseases (NCDs) like cardiovascular disease and hypertension (Cohen et al., 2007) . In this paper, we hypothesize that the disparity in BIPOC COVID-19 related outcomes may inpart be attributable to Stress-NbA associated immune perturbations. Specifically, we hypothesize that stress leads to a double hit on the inflammatory response: 1) reducing anti- By interrogating this hypothesis, we may learn how to help BIPOC patients reduce their vulnerability to COVID-19 and other viral illness effects and at the same time learn more about the intricate relationship between the brain's psychosocial threat response system and its microbial threat response system.

Given the distinct experiences of racial/ethnic groups in the United State, our study has largely focused in the US. However, accumulating body of evidence shows that indigenous people around the world have an increased vulnerability to COVID-19 due to systemic inequalities and marginalization. This is now recognized globally and has led to a call to action (McLeod et al., 2020; Power et al., 2020; Zavaleta, 2020) . Hence, the hypothesis presented here may also have implications in other countries.

Toxic stress is associated with the development of MetS and socioeconomic and discrimination stress is known to exacerbate the precursor state of allostatic overload that predisposes to MetS. (Laurencin and McClinton, 2020; Osei and Gaillard, 2017) Allostasis is the capacity to achieve stability through change (McEwen, 1998a; Sterling P and J., 1998) . It refers to biological mechanisms that protect the body by maintaining an internal physiological balance. 21 It takes metabolic energy for the brain to maintain physiological parameters within a normative range in response to external and internal environmental stressors and this can lead to the metabolic wear and tear referred to as allostatic overload. Chronic stress, early trauma, hypercortisolism J o u r n a l P r e -p r o o f that react to stress, the amygdala plays a particularly prominent role. (Ross et al., 2017) The amygdala is charged with keeping the organism safe and thus can be considered the brain's fear conditioning center (Jovanovic and Ressler, 2010) .As part of its job, when threat is perceived in sensory information sent from the thalamus, the amygdala expresses the excitatory neurotransmitter glutamate, which alerts many brain regions including 3 hypothalamic nuclei.

The tripartite stress response system, includes the paraventricular nucleus that will transmit downstream to the pituitary and the adrenal cortex--the so-called hypothalamic-pituitaryadrenal (HPA) axis--resulting in output of the stress hormone cortisol; the lateral hypothalamus, which, along with stimulation of the locus coeruleus, will stimulate catecholamines in the sympathetic nervous system (SNS), and the mediobasal hypothalamus, which will help to trigger an inflammatory response syndrome (IRS). The heightened SNS activity stimulates the production and release of leukocytes from the bone marrow niche, which primes the body for heightened chronic inflammation (Heidt et al., 2014) .

Vertebrates evolved in challenging microbial environments so natural selection favored the development of a hair trigger innate immune response set in motion by peripheral blood mononuclear cells (PBMCs), which when activated can become macrophages. Through the intercession of the transcription factor, NF-kB, these cells produce pro-inflammatory cytokines, which in short order precipitate a non-specific inflammatory response, while also setting in motion the maturation of a specific adaptive immune response comprised of cellular and humoral arms that is carried out by lymphocytes (T cells and B cells). The humoral immune response in particular can take up to a month and is dependent on B cells specialized to produce antibodies to neutralize specific antigens of pathogens.

When these immune defenses are used acutely and then decommissioned, the organism maintains its mitochondrial energy balance and reserve capacity while also remaining safe.

When mammals evolved, another survival challenge joined the microbial threat. Since the hallmark of the mammalian survival strategy is secure attachment to parental and other social J o u r n a l P r e -p r o o f objects, largely mediated by a part of the paralimbic cortex called the anterior cingulate cortex (ACC), the fear of separation became the source of great amygdalar distress. A particular form of the acute stress response engendered by the amygdala became prominent in the life of mammals threatened with separation from social attachments. In the course of evolution, the acute stress response became entwined with the acute inflammatory response, which also relies on the tripartite stress response system for mediation and modulation (Raison and Miller, 2013 ).

An important component of the innate immune response involves the canonical pathway of the nod like receptor family pyrin domain containing 3 gene (NLRP3) inflammasome activation. This process is thought to involve two phases (Kelley et al., 2019) . The initial priming phase involves pattern recognition signalling through toll like receptor 4 (TLR4) recognized pathogen associated molecular patterns (PAMPs) such as lipopolysaccharides (LPS); or through signs of cell damage such as holes in the cell membrane. In the case of LPS, NF-kB is activated, which drives transcription of IL-1β and NLRP3 genes, leading to translation of pro-IL-1β and inflammasome components. When these proteins reach a certain level, the cell is primed. In the second phase, a second activating signal causes NLRP3 to form a complex, which recruits pro-caspase-1, which is then converted to the mature enzyme caspase-1. Caspase-1 is capable of catalyzing the conversion of pro-IL-1β to mature pro-inflammatory cytokine IL-1β (Frank et al., 2016) . IL-1β can then start a cascade with the production of other pro-inflammatory cytokines and mediators, resulting in an amplified inflammatory response. Margolis (2015) has proposed the "immunoactivation hypothesis" to explain the interrelationship of MetS and the immune response. Diseases are triggered by various etiological agents including microbes (PAMPS) as well as non-pathogen factors (non-PAMPs). But disease progression requires immunoactivation (Margolis, 2015) . While this immunoactivation can be caused by these agents and other factors, it may also precede the particular etiological agent in the context of significant stress and this then compounds the inflammatory disease process due J o u r n a l P r e -p r o o f to oxidative stress, impaired glucose and lipid metabolism, and disrupted neurohormonal modulation (Margolis, 2015) .

The immune system is well integrated with the stress response system in large part due to the intercession of NF-κB (Bierhaus et al., 2004) . Catecholamines from SNS fibres increase NF-kB DNA binding in immune cells, including the macrophage (Miller et al., 2009a) . In addition, the high mobility groupbox-1 (HMGB-1) protein is a damage associated molecular pattern (DAMP) that signals cellular distress and stimulates an innate immune response. Indeed, macrophages, as master regulators of innate immunity, release HMGB-1 (Castiglioni et al., 2011) .Once released into the extracellular space HMGB-1 initiates an IRS through effects at TLRs.

It is postulated that microglia release HMGB-1 in response to acute or chronic psychosocial stress (Frank et al., 2016) . Microglia have receptors for stress hormones and IL-1β. In this way psychological stress can cause neuroinflammation via a non-PAMP stress related pathway.

There are likely many other molecules (for example heat shock proteins) that signal in a similar manner.

With regard to severe COVID-19, it has been shown that an outburst of catecholamines The effect of psychosocial stress, such as that caused by experiences of racism and discrimination among ethnic minorities and those with low SES, on glucocorticoids (GCs), HMGB-1 and the NLRP3 inflammasome provides a potential mechanism by which such stress exposure could prime neuroinflammatory and peripheral inflammatory processes. In response J o u r n a l P r e -p r o o f to stressors perceived as "dangers", GCs might precipitate the release of HMGB-1 by macrophages and in the brain by microglia. With respect to COVID-19, it is of interest that stress may induce inflammatory priming to subsequent immune challenges, such as SARS-CoV-2 infection, since macrophages and microglia are potential substrates for stress induced priming.

Recently much has been learned about the epigenetic control of gene activation through stress mechanisms. Indeed, there appears to be a transcriptomic signature of chronic stress. Thus, if an individual is exposed to an extracellular pathogen such as a bacterium, the intracellular transcription factors NF-κB and activator protein 1 (AP-1) are triggered by bacterial PAMPs. A proinflammatory cascade with stimulation of immune response genes for IL1β, IL6, IL8, and TNF, results in increased output of these proinflammatory cytokines. Thus, it appears that MBIs may attenuate the adverse impact that chronic stress has on gene expression, with implications for health promotion and illness prevention (particularly during the pandemic), notably among individuals with heightened chronic stress, including marginalized racial or ethnic groups or individuals of low SES.

To summarize, if the BIPOC population exposed to chronic stress-induced non-PAMP inflammation were to exhibit a type I IFN anti-viral handicap during a coronavirus pandemic, in which the virus can exploit epigenetic strategies to further disrupt host type I IFN anti-viral defenses, one might expect the excess morbidity and mortality we are seeing in racial and ethnic minorities during the COVID-19 crisis. Explicating the assortment of mechanisms that contribute to delayed type I IFN defense and to the different phases of inflammatory response J o u r n a l P r e -p r o o f will be crucial to understanding COVID-19 disease risk and outcome. It appears there is enough evidence suggesting chronic discrimination stress is one driver we must consider.

Mounting a threat-provoked premonitory immune response, would be evolutionarily advantageous. In fact, this kind of precautionary response occurs when immune response genes respond to psychosocial brain signals suggesting that a non-pathogen social danger is present with wounding and concomitant bacterial infection potential (Slavich and Cole, 2013) .

The innate IRS can indeed be activated in a non-PAMP fashion when someone is subjected to adverse interpersonal conditions such as social conflict, rejection, isolation, or exclusion and low SES. This may relate to the extraordinary importance social attachment and its survival advantage plays in our mammalian evolutionary history (Fricchione, 2011; MacLean, 1990) . This unholy alliance of a severe pathogen-associated immune response secondary to the COVID-19 virus and a persistent non-PAMP CTRA immune response related to psychosocial stress in minority populations and the elderly, may be expected to increase the morbidity and mortality of these patients.

Because social attachment is so central to our evolutionary survival strategy, when it is threatened, our amygdalae erupt with alarm (Fricchione, 2011; MacLean, 1990) . Amygdalar overactivation in the face of stress leads to SNS overdrive, which can produce transcriptional alterations in differential gene expression (Irwin and Cole, 2011 ).

Recently a model has been developed to help explain the stress-related cascade that can lead to PBMC changes commensurate with the CTRA response and downstream morbidity. When the amygdala perceives environmental threats, it will produce excitatory glutamatergic signals J o u r n a l P r e -p r o o f in axonal flow from the central amygdala nucleus. This will lead to hypothalamic and brainstem stimulation that results in hormonal, autonomic, and behavioral changes reflective of the fear and stress response. In stressed medical ICU physician trainees for example, it has been shown that chronic stress induces monocytosis and neutrophilia (Heidt et al., 2014) . In mice, stress activates upstream hematopoietic stem cells when heightened sympathetic drive releases norepinephrine. Norepinephrine stimulates the β 3 adrenergic receptor to activate bone marrow niche cells to increase hematopoietic stem cell proliferation resulting in output of neutrophils and inflammatory monocytes (Heidt et al., 2014) .

A longitudinal cohort study using positron emission tomography/computerized tomography (PET/CT) and psychometric testing showed that amygdala activation (AmygA) in stressed subjects correlated with increased bone marrow activation and myelopoiesis as well as with arterial wall inflammation and was predictive of future cardiac events (Tawakol et al., 2017) .

This suggests that heightened AmygA is associated with hematopoietic overactivity and arterial inflammation, and that activation of this neural-hematopoietic-arterial network predicts the development of future major adverse cardiovascular events (MACE).

In a follow up PET/CT study, Dar and colleagues (2020) were able to show that individuals with lower AmygA, despite chronic exposure to socioeconomic or environmental stressors, enjoyed relative protection from cardiovascular disease (i.e. a > 50% decreased MACE risk within 5 years of imaging) (Dar et al., 2019) . This protective effect may be secondary to reduced production of bone marrow derived immune cells and less atherosclerotic inflammation. The authors suggest that enhancing neurobiological resilience, defined as lower AmygA despite chronic stress exposure, may decrease the risk of cardiac disease.

In another recent study, lower SES was associated with higher AmygA; and independently predicted MACEs presumably through a cascade that includes heightened AmygA, bone marrow activation, and arterial inflammation (Tawakol et al., 2017) . These findings illuminate a Stress-NbA mechanism by which SES disparities may potentiate adverse health outcomes.

The results of this study may directly relate to the disparities seen with COVID-19 because chronic stressors, known to be associated with AmygA and cardiac disease risk, were quantified using individual home addresses reflecting differential stress exposure due to neighborhood median household income, and crime rate. Subjects living in the lowest-income neighborhoods had 4 times the risk of a MACE over the next 5 years when compared to subjects living in the highest-income neighborhoods .

It has also been demonstrated that experimental inflammatory challenge can selectively increase AmygA to socially threatening images determined with fMRI. Interestingly, this activity correlated with feelings of social disconnection (Inagaki et al., 2012) . With regard to COVID-19 infection, minority perception of threat signals in the context of inflammatory challenge may exacerbate vulnerability to morbidity and mortality from an AmygA cascade that leads to bone marrow activation of hematopoiesis and arterial inflammation associated with NF-kB transcriptional overactivation and the CSS.

Psychosocial stress modulates mitochondrial functioning through physiological and behavioral effects. This implies that the brain provides one level of analysis of psychosocial stress signals while mitochondria serve as monitors of stress at the cellular level.

Mitochondria provide energy as well as signals that mediate the organism's capacity to adapt to stress. Psychosocial stress can get translated into metabolic activation and processed at the cellular level as oxidative stress (McEwen, 1998b) . It takes metabolic energy input for the brain to maintain physiological parameters within a normative range in response to external and Switching macrophage polarization states is an emerging idea for managing inflammatory diseases and could be conceptualized as a therapeutic target to arrest the kind of CSS that has overtaken many patients with severe COVID-19 infections. Mitochondrial manipulation would constitute an approach of choice to facilitate macrophage repolarization and reduce the harmful effects of chronic toxic stress in racial and ethnic minority populations at risk.

Another point that merits discussion is what current evidence says about treatment effects on COVID-19 disease progression and mortality in BIPOC communities. It is of interest that early administration of IFN-a2b in one study appeared to be associated with reduced in-hospital mortality as opposed to late interferon therapy, which was associated with increased mortality and delayed recovery. This suggests that the timing of IFN therapy is key for favorable responses in COVID-19 patients and also suggests that, in BIPOC patients, whom we hypothesize are starting from a lower IFN-based anti-viral immune response, early IFN based therapy for COVID-19 may be especially beneficial . This is because it is increasingly recognized that starting out with an imbalanced IFN response may contribute greatly to the pathophysiology of COVID-19 (Acharya et al., 2020) .

It is also of interest that preliminary data from the Randomized Evaluation of COVID-19 Therapy (RECOVERY) suggest that dexamethasone, which as a treatment can be expected to dampen an overactive NF-kB dominated cytokine storm response, appears to be beneficial for those participants treated well into the symptomatic phase, with the onset of hypoxemia. There was, however, possible harm when dexamethasone was used to treat participants without severe COVID-19 symptoms. Therefore, although not conclusive, the early findings form the RECOVERY trial do not support use of dexamethasone for patients with milder disease (Johnson and Vinetz, 2020).

According to our hypothesis, BIPOC patients with COVID-19 may be at excess risk due to their chronic stress related activation of the NF-kB pro-inflammatory pathway. Therefore, since they start from a primed baseline, they may be more susceptible to quickly progress to a severe COVID-19 precipitated IRS. It will be interesting to see whether expeditious use of dexamethasone in BIPOC patients, under conditions of severe COVID-19, is particularly therapeutic.

This discussion suggests to us that the BIPOC population, who we hypothesize to be at risk both from too little Type I IFN pathway activation early in their exposure to COVID-19 and an overly robust NF-kB pathway activation that eventually leads them to severe status, may especially require early treatment with IFN therapy, with a steroid like dexamethasone at the ready if and when severe symptoms emerge. As treatment trial data accumulates, it will be important to tease out relative response rates in BIPOC subjects with an eye toward this hypothesis.

The interaction between social conditions and communicable diseases is being illuminated by the SARS-CoV-2 pandemic. The evolutionary relationship between the inflammatory bias of our heritage in a dirty microbial world and our social attachment bias as mammals represents our bimodal survival strategy.

The necessary bidirectional communication between the central nervous system (CNS) and the immune system is the product of these evolutionary selection biases, but it has become a conditional handicap in the modern world of chronic stress, especially for individuals of Prior studies have shown the impact of chronic stress on viral diseases Cohen et al (1991) .

observed that higher levels of perceived stress correlate with greater risk of developing coronavirus infection after nasal inoculation (Cohen et al., 1991) . Psychological stress also predicts a greater expression of illness and an increased production of IL-6 in response to an upper respiratory infection (Cohen et al., 1999) . The present viral pandemic emphasizes the double jeopardy at risk populations face from the combination of stress immunoactivation and diminished anti-viral immune response.

What is to be done? Structural racism creates an enormous toll of psychosocial stress with vulnerability to NCDs and to viral communicable diseases (CDs). Sociopolitical movements to dismantle structural racism may benefit from a deeper understanding of the physical consequences of maltreatment of racial and ethnic minorities as illuminated in the multifaceted impacts of the COVID-19 pandemic.

A population-based approach to the public health problems of racial and ethnic minority groups is mandatory. At the turn of the 20 th century, poor people succumbed at alarming rates to CDs.

In light of public health advances like water chlorination and vaccination later in the century, annual death rates dropped by more than 90% to approximately 50 per 100,000 people from 800 per 100,000 (Centers for Disease and Prevention, 1999). The development and implementation of community-based interventions are now needed to reduce the secondary effects of the social, behavioral, and economic determinants of illness (Borja, 2020) . A trans-NIH working group on the social, behavioral, and economic impact of COVID-19 has recommended looking at such interventions. We would add the challenge of homelessness, a condition overrepresented in racial and ethnic minorities, to the list of potentially modifiable risk factors since people experiencing homelessness have been estimated to be twice as likely J o u r n a l P r e -p r o o f to be hospitalized, two to four times as likely to require critical care and twice as likely to die as the general population (Culhane et al., 2020) .

Population based scalable MBIs designed to mitigate stress-related risk and promote resilience or recovery in high-risk populations, when combined with the structural community-based interventions suggested above, could help improve our long-term response to the pandemic and help prepare at-risk communities more effectively for future public health emergencies. In addition to the extensive acute care medication and vaccine trials that are underway, there is a need to study the potential of certain medications, such as melatonin, minocycline, prazosin, and metformin, along with behavioral and MBI approaches, to manipulate the bidirectional CNS-immune regulatory system by affecting gene expression changes in stress and the immune response.

Finally, opportunities may exist for Big Data to help reduce health care disparities (Zhang et al., 2017) . . Machine learning and natural language processing (NLP) could use coded demographic and social determinant data extant in electronic medical records to improve longitudinal approaches to evidence-based care for the most discriminated against groups in our society.

Strengthening surveillance by connecting geographical and social determinant variables for minority populations residing in certain zip codes to clinical outcomes would be of assistance. If carried out ethically, we may be cautiously optimistic that this enhanced level of understanding can improve our chances of effectively intervening in a future viral pandemic to both prevent illness and treat it when it occurs.

There are challenges to the hypothesis presented here indicating the need for more research.

While there is growing consensus that chronic social stress triggers a pro-inflammatory state marked by elevated antibacterial gene expression pathways along with reductions in antiviral defense, and that social subordination has the power to affect the gene expression response to In addition, IFN-induced gene expression has been found to be higher in African American systemic lupus erythematosus (SLE) patients than in European American patients (Ko et al., 2013) . Nuclear breakdown debris and subsequent antibody complexes lead to over-activation of the innate immune response through TLR and type I IFN activation in Black SLE patients.

Perhaps most challenging is work from the UCLA group in which discrimination stress and racial differences in WBC gene expression were examined (Thames et al., 2019) . In one study, they found greater activation of pro-inflammatory NF-kB and AP-1 pathways in African Americans versus European Americans but also found elevated transcription of innate antiviral response type I IFN factors. There did not appear to be the kind of deficit in antiviral response gene activation seen in other socially challenging contexts in previous studies. The authors speculate that differences in viral disease background (some subjects were stable chronic HIV + patients) or in SES or other environmental circumstances may have played a role. It is notable however, that the Log2 transcription factor-binding motifs ratio, when discrimination stress was considered, did show that antiviral response transcription factors (IRFs) were in the negative range while NF-kB and AP-1 were in the positive range relative to Caucasians. type I IFN defense when exposed to a COVID-19 viral load. Furthermore, single cell analysis would be useful for looking at some of the pathways described and enhance our understanding of specific immune processes that may increase relative risk for SARS-CoV-2 infection.

We have learned the hard way that to ignore the ample scientific warnings of our lack of preparedness for a pandemic in our country was pure folly. Sadly, this failure has fallen hardest on our disadvantaged minorities. Their social determinants of illness vulnerability may reflect, to some extent, a combination of stress response and immune response related factors aligned against them, leading to excess morbidity and mortality in this COVID-19 pandemic. We hope the hypothesis presented here will prompt studies designed to confirm or reject it. And if confirmed we hope it will help society be better prepared to help these at-risk populations in the future.

J o u r n a l P r e -p r o o f

Dysregulation of type I interferon responses in COVID-19

Designing and Assessing Multilevel Interventions to Improve Minority Health and Reduce Health Disparities

Why inequality could spread COVID-19

Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses

Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics

NF-kappaB as a molecular link between psychosocial stress and organ dysfunction

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Trans-NIH workgroup on social, behavioral, and economic impact of COVID-19

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

Expression of socially sensitive genes: The multi-ethnic study of atherosclerosis

What Is the Molecular Signature of Mind-Body Interventions? A Systematic Review of Gene Expression Changes Induced by Meditation and Related Practices

High-mobility group box 1 (HMGB1) as a master regulator of innate immunity

CDC, 2020. COVID-NET: COVID-19-Associated Hospitalization Surveillance Network

Control of infectious diseases

Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection

Socioeconomic status and health: mediating and moderating factors

Psychological stress, cytokine production, and severity of upper respiratory illness

Psychological stress and disease

Psychological stress and susceptibility to the common cold

Human social genomics

The Conserved Transcriptional Response to Adversity

Transcriptional modulation of the developing immune system by early life social adversity

Social regulation of gene expression in human leukocytes

Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies

Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling

Estimated emergency and observational/quarantine capacity need for the US homeless population related to COVID-19 exposure by county; projected hospitalizations, intensive care units and mortality

Psychosocial Stress and Cardiovascular Disease

COVID-19 exacerbating inequalities in the US

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Inflammaging and 'Garb-aging

Stress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disorders

Compassion and healing in medicine and society. On the nature and uses of attachment solutions for separation challenges

Chronic inflammation in the etiology of disease across the life span

Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

The Metabolic Syndrome in African Americans: a review

Chronic variable stress activates hematopoietic stem cells

Inflammation selectively enhances amygdala activity to socially threatening images

Reciprocal regulation of the neural and innate immune systems

Molecular mechanisms regulating NLRP3 inflammasome activation

Dexamethasone in the management of covid -19

How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Chronic stress and age-related increases in the proinflammatory

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients

The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities

Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults

Role in paleocerebral function

Immunoactivation at the crossroads of human disease

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

Pathophysiology of the metabolic syndrome

Protective and damaging effects of stress mediators

Stress, adaptation, and disease. Allostasis and allostatic load

Causes of metabolic syndrome and obesity-related co-morbidities Part 1: A composite unifying theory review of human-specific co-adaptations to brain energy consumption. Arch Public Health 72

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

COVID-19: we must not forget about Indigenous health and equity

Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

Infectious disease and psychoneuroimmunology

Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling

A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling

Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey

National Center for Health Statistics Weekly Updates by Select Demographic and Geographic Characteristics. Provisional Death Counts for Coronavirus Disease 2019 (COVID-19)

Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome

Mortality Disparities in Racial/Ethnic Minority Groups in the Veterans Health Administration: An Evidence Review and Map

Cardiovascular activity and the antibody response to vaccination

An energetic view of stress: Focus on mitochondria

Earlylife and adult socioeconomic status and inflammatory risk markers in adulthood

Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis

COVID-19 and Indigenous Peoples: An imperative for action

Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income

Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias

Genes and social behavior

An Integrated Neuroscience Perspective on Formulation and Treatment Planning for Posttraumatic Stress Disorder: An Educational Review

Social history and exposure to pathogen signals modulate social status effects on gene regulation in rhesus macaques

Metabolic syndrome: prevalence among American Indian and Alaska native people living in the southwestern United States and in Alaska

The Emerging Field of Human Social Genomics

Social status alters immune regulation and response to infection in macaques

Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3

Disruption of a selfamplifying catecholamine loop reduces cytokine release syndrome

Allostasis: A new paradigm to explain arousal pathology, in Handbook of life stress, cognition and health

RACIAL DISPARITIES IN HEALTH: How Much Does Stress Really Matter?

Coronavirus Disease 2019 Case Surveillance -United States

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study

Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease

Experienced discrimination and racial differences in leukocyte gene expression

Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages

Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition

Alpha-1 adrenergic receptor antagonists for preventing acute respiratory distress syndrome and death from cytokine storm syndrome

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients

COVID-19 and Health Equity-A New Kind of

COVID-19: review Indigenous peoples' data

Big Data Science: Opportunities and Challenges to Address Minority Health and